TCL Archive Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study December 26, 2014
TCL Archive Also Von Eschenbach role in industry program raises new concerns of conflict of interest. November 23, 2005
TCL Archive Community Clinical Oncology Program Renewed, NCI Hopes To Restore Cuts In ’08. March 30, 2007